Oct 2025 – Present · 6 mos

Jan 2022 – Oct 2025 · 3 yrs 9 mos

• Role Evolution: transitioned from leading clinical analytics delivery to architecting enterprise AI strategy.
• Phase II: Enterprise AI & Strategy Lead (2024 – 2025)
• AI incubation: Orchestrated an enterprise-wide AI incubation pipeline managing 300+ initiatives. Prioritized high-impact use cases to deliver $199M in documented business value across multiple business units.
• Governance & Operations: Designed and implemented the "Smart Triage" framework and worked with AI Review Board (AIRB), to establish the governance protocols that allow rapid, safe deployment of GenAI and predictive models.
• Phase I: Clinical Analytics & Client Delivery (2022 – 2024)
• Program Leadership: Managed large-scale Population Health and HEOR engagements, acting as the primary bridge between technical teams and clinical stakeholders.
• Solutioning: Developed technical solutions for Payers and Providers, leveraging deep expertise in healthcare data standards and clinical workflows to drive operational improvements.

Jul 2018 – Jan 2022 · 3 yrs 6 mos

• Clinical Innovation (mSTOPS): Served as a Lead Researcher for the landmark mSTOPS clinical trial, a siteless digital health study using wearable ECG sensors. Synthesized findings into peer-reviewed publications (PLoS One, Heart Rhythm O2) that validated digital screening protocols for Atrial Fibrillation.
• ​HEOR & Market Access Strategy: Directed a high-performance team of 4 analysts to deliver 20+ complex HEOR and RWE studies across Diabetes, Autoimmune, and Cardiovascular therapeutic areas. Generated critical evidence to support market access, pricing, and reimbursement strategies for pharmaceutical clients.
• ​Economic Modeling: Led comparative effectiveness and "Burden of Illness" analyses, transforming Real-World Data (claims, EHR) into actionable commercial insights that optimized formulary positioning.
• ​Operational Excellence: Oversaw study design and protocol development, ensuring rigorous adherence to scientific methodology while managing client timelines and P&L targets for research initiatives.

Jan 2017 – Jul 2018 · 1 yr 6 mos

• Determined impact of therapies and technology on clinical outcomes among diabetics in real-world healthcare setting.
• Studied the impact of Disease Activity measurement on choice of therapy among patients with RA with inadequate response to first line therapy.
• Characterized members with recurring infections and analyzed treatment patterns.

Jun 2015 – Jan 2017 · 1 yr 7 mos

• Led a team of analysts to develop analytical reports summarizing healthcare utilization and clinical outcomes; managed client communication and project planning, tracked progress and ensured timely delivery of Analytic Impact Reports.
• Designed and developed population health reports to examine the effects of managed care activity on the treatment, costs and outcomes of care among engaged members.
• Developed market level scorecards and dashboards to present cost and clinical trend based actionable insights to clinical program managers.

Dec 2013 – Jun 2015 · 1 yr 6 mos

• Collaborated with business process teams in Manila, Philippines to optimize utilization management and member services.
• Identified opportunities of using data driven interventions to improve member-nurse interactions during enrollment outreach; Subsequent time-motion study observed 21% reduction in average call handle time and improved efficiency.
• Analyzed calling patterns and connect rates across member segments to facilitate efficient calling; Identified opportunities of improvement in provider outreach using healthcare measure prioritization and provider segmentation.
• Assisted with technical and administrative management of team projects and monitored performance targets for the team; Planned and executed mentoring programs for new team members to develop technical capabilities and domain knowledge.

Jun 2012 – Jan 2014 · 1 yr 7 mos

• Performed data preparation and analysis of healthcare utilization, medical spend trends and benchmarks to support health plan managers in strategic engagement with large plan sponsors.
• Evaluated program participation in medical management programs; assessed medical and pharmacy utilizations, high cost outliers, care coordination and adverse events to determine population health metrics.